Free Trial

Fate Therapeutics (FATE) Insider Trading & Ownership

Fate Therapeutics logo
$1.27 +0.02 (+1.60%)
As of 01/17/2025 04:00 PM Eastern

Fate Therapeutics (NASDAQ:FATE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.00%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$668,579.52
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$34,597.29
Get FATE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Fate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FATE Insider Buying and Selling by Quarter

Fate Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/10/2025Bahram ValamehrCEOSell8,705$1.54$13,405.70  
1/10/2025Jerome Charles BressiInsiderSell5,980$1.55$9,269.00  
12/20/2024Redmile Group, LlcDirectorBuy397,964$1.68$668,579.52  
8/6/2024Yuan XuDirectorSell633$4.23$2,677.59  
1/29/2024Edward J Dulac IIICFOSell1,849$5.00$9,245.00  
(Data available from 1/1/2013 forward)

FATE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Fate Therapeutics includes Bahram Valamehr, Brian T Powl, Cindy Tahl, Edward J Dulac III, J Scott Wolchko, Jerome Charles Bressi, John Mendlein, Mark Plavsic, Redmile Group, Llc, Shefali Agarwal, Yuan Xu, and Yu-Waye Chu. Learn more on insiders at FATE.

5.00% of Fate Therapeutics stock is owned by insiders. Learn more on FATE's insider holdings.

The following insider purchased FATE shares in the last 24 months: Redmile Group, Llc ($1,108,603.12).

Insiders have purchased a total of 488,294 FATE shares in the last 24 months for a total of $1,108,603.12 bought.

The following insiders have sold FATE shares in the last 24 months: Bahram Valamehr ($62,772.68), Brian T Powl ($18,768.98), Cindy Tahl ($47,519.38), Edward J Dulac III ($78,196.82), J Scott Wolchko ($62,888.67), Jerome Charles Bressi ($9,269.00), Yuan Xu ($24,329.11), and Yu-Waye Chu ($16,635.24).

Insiders have sold a total of 81,109 Fate Therapeutics shares in the last 24 months for a total of $320,379.88 sold.

Fate Therapeutics Key Executives



This page (NASDAQ:FATE) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners